E2 (Endovascular Engineering, Inc.), a medical device company advancing endovascular therapies, today announced the completion of patient enrollment in the pivotal cohort of its ENGULF Investigational ...

The meeting was held this afternoon in Amsterdam, the Netherlands at 4:00PM CET. Full details of the resolutions approved ...

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Shareholders approve all proposed resolutions EINDHOVEN, The ...

The webcast will be held on June 17, 2025, at 2:00PM CET / 08:00AM ET. It will be hosted by CEO Dave Marver. To join the ...

ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function ...

ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury ...

INDIANAPOLIS— They gave out the Tony Awards days earlier, but they should have waited a week. The return of Caitlin Clark to the Indiana Fever lineup from injury merited recognition as the Best ...

Tufts Medicine has named a former Penn Medicine executive as the new president of Tufts Medical Center, the system’s academic ...

Marcel Vernon, Sr., head of the Massachusetts Convention Center Authority, said the convention center's existence "would not have been possible without the leadership of Mayor Menino.” ...

The Boston Celtics have made their second significant trade in as many days. Less than a day after sending Jrue Holiday to ...

Dana-Farber Cancer Institute got approval from Boston Planning and Development Agency Board on its design for a cancer hospital in Boston.

Children exposed before birth to synthetic compounds called "forever chemicals" had higher blood pressure during their ...